Two Tests with Same Reference [Design Issues]

posted by Noha Abdeljawad – Cairo, Egypt, 2012-11-27 09:18 (4954 d 10:31 ago) – Posting: # 9598
Views: 27,296

Dear All,
In the bioequivalence center I work in, we need to carry out a BE study for two generic drugs containing the same active ingridient in the same strength from two different manufacturers. Since they both require using the same reference drug, we thought we'd do one crossover study of 3 phases, with one week (washout period) between each phase and the next. On each phase, each of the volunteers took test1 (A), test2 (B) or reference (C). By the end of the study, each of the three products will be adminstered to each volunteer. Bioequivalence assessment will be based on comparing PK parameters of A with C and then of B with C.

Is it ok to use this study design?
How will this affect ANOVA analysis?
Is this design referred to as two-way or three-way?

Thanks

Best Regards
Noha Abdeljawad

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
119 visitors (0 registered, 119 guests [including 12 identified bots]).
Forum time: 20:49 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5